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Abstract
Background: The gene expression profile of a tissue averages the expression profiles of all
cells in this tissue. Digital tissue deconvolution (DTD) addresses the following inverse problem:
Given the expression profile y of a tissue, what is the cellular composition c of that tissue? If
X is a matrix whose columns are reference profiles of individual cell types, the composition c
can be computed by minimizing L(y − Xc) for a given loss function L. Current methods use
predefined all-purpose loss functions. They successfully quantify the dominating cells of a tissue,
while often falling short in detecting small cell populations.
Results: Here we learn the loss function L along with the composition c. This allows us to adapt
to application-specific requirements such as focusing on small cell populations or distinguishing
phenotypically similar cell populations. Our method quantifies large cell fractions as accurately
as existing methods and significantly improves the detection of small cell populations and the
distinction of similar cell types.
1 Introduction
Different tissues of the body have different cellular compositions. The composition of tumor tissue
is different from that of normal tissue. Also, when comparing two tumor tissues, their cellular
composition can differ greatly. The relatively small populations of tumor-infiltrating immune cells
are of particular importance. They affect progression of disease (Galon et al., 2006) and success
of treatment (Fridman et al., 2012). Immune therapies block communication lines between tumor
cells and infiltrating immune cells. Whether they are successful or not depends on the presence,
quantity, and molecular sub-type of the infiltrating immune cells (Hackl et al., 2016). Immune-cell
populations are typically small, and their molecular phenotype can be difficult to observe under
the microscope. Single-cell technologies such as fluorescence-activated cell sorting (FACS; Ibrahim
and van den Engh (2007)), cytometry by time-of-flight (CyTOF; e.g. Bendall et al. (2011)), and
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single-cell RNA sequencing (Wu et al., 2014) assess molecular features on the single-cell level and
can thus be used to determine the cellular tissue composition experimentally.
A more cost- and work-efficient alternative to single-cell assays is a combination of bulk-tissue
gene expression profiling with digital tissue deconvolution (DTD) (Lu et al., 2003; Abbas et al.,
2009; Gong et al., 2011; Qiao et al., 2012; Altboum et al., 2014; Newman et al., 2015; Li et al.,
2016). DTD addresses the following inverse problem: given the bulk gene expression profile y of
a tissue, what is the cellular composition c of that tissue? Supervised DTD assumes that there is
a matrix X whose columns are reference profiles of individual cell types. The composition c of y
can be computed by minimizing L(y −Xc) for a given loss function L. Competing DTD methods
use different predefined all-purpose loss functions L and different estimation algorithms to distil c
from y and X.
The practical objective of DTD is to estimate c correctly, while the formal objective of common
DTD algorithms is to estimate y correctly. If tissue expression profiles were exact mixtures of
reference profiles, existing methods should work perfectly. They are not and this causes problems:
(1) Collections of references profiles can be incomplete. There might be cells in the tissue
that are not represented by the reference profiles. In that case the global DTD problem is
not solvable, and DTD-algorithms will compensate for the contributions of these cells by
increasing the frequencies of other cell types.
(2) Small cell fractions are hard to quantify. From a practical point of view this is probably
the most important point, and improvements are needed badly. Immunological cell popula-
tions in a tumor are small, but they may determine the reaction of a tumor to immunotherapy.
Therefore, DTD algorithms must use faint signals from small cell populations more effectively.
(3) Some cell types can hardly be distinguished by their expression profiles. The
profile of an epithelial cell differs greatly from that of a lymphoid cell. For two immunological
sub-entities of CD8+ T cells the differences are more subtle. The more similar two cell types
are, the more similar are their expression profiles, and the more difficult is their distinction.
In summary, different applications need different approaches. One way to adapt the estimation
of c is to adapt the loss function L. If the focus of an application is on a predefined set of cell
types, genes that are informative to distinguish exactly these cells should dominate L. This is even
more important if the focus is on small cell populations, the faint signals of which must not be
suppressed. Unfortunately, it is not clear a priori which genes to ignore and which to focus on.
2 Methods
2.1 Notations
Let X ∈ Rp×q be a matrix with cellular reference profiles X·,j in its columns, where the dot stands
for all row indices. Xij is the reference expression value of gene i in cells of type j, p the number of
genes, and q the number of cell types in X, respectively. We further introduce a matrix Y ∈ Rp×n
with bulk profiles of n cell mixtures Y·,k in its columns and a matrix C ∈ Rq×n with the cellular
compositions of the mixtures C·,k as columns.
2
2.2 Loss-function learning
Following the established linear DTD algorithms, we approximate the mixture Y·,k by a linear com-
bination of reference profiles (the columns of X) with C.,k as weights and estimate the composition
of the k-th mixture C·,k by minimizing
Lg(Y·,k −XC·,k) , (1)
where
Lg = ||diag(g)(Y·,k −XC·,k)||22 . (2)
In contrast to standard DTD algorithms, which determine g by prior knowledge or separate statis-
tical analysis, we will learn g directly from data. To this end we assume that we have a training
set of mixtures Y·,k from a specific application context with known cellular compositions C·,k. The
entries of g are the gene weights that define the loss function. We want to learn g from the training
data such that minimizing Lg(y − Xc) with respect to c yields accurate quantifications of cell
populations for future samples with similar characteristics as those used for training.
Our method has two nested objective functions: An outer function L(g) and an inner function
Lg, which is here given by equation (2). L evaluates discrepancies between the estimated and the
true cellular frequencies of cell types across samples:
L(g) = −
q∑
j=1
cor(Cj,·, Cˆj,·(g)) subject to gi ≥ 0 and ||g||2 = 1 , (3)
where the Cˆj,·(g) are the estimates of Cj,· given g. To evaluate L(g) we need to calculate all Cˆj,·(g),
which requires optimizing Lg with respect to all C·,k. Note that if gˆ is a minimum of L, so is αgˆ.
The constraint ||g||2 = 1 is thus needed to ensure unique solutions.
The minimum of Lg can be calculated analytically, yielding
Cˆ(g) = (XTΓX)−1XTΓY (4)
with Γ = diag(g). Inserting this term into L leaves us with a single optimization problem in g. We
minimize L by a gradient-descent algorithm. Let µj and σj be the mean and standard deviation of
Cj,·, respectively. We obtain the gradient
∂L(g)
∂gi
=
q∑
j=1
n∑
k=1
1
σj σˆj
(
cov(Cj,·, Cˆj,·)
nσˆ2j
(
Cˆjk − µˆj
)− 1
n
(Cjk − µj)
)
∂Cˆjk(g)
∂gi
(5)
with
∂Cˆ(g)
∂gi
= (XTΓX)−1XT δ(i)
(
1−X(XTΓX)−1XTΓ)Y , (6)
where δ(i) ∈ Rp×p is defined as
δ(i)jk =
{ 1 if i = j = k,
0 else.
(7)
The constraints ||g||2 = 1 and gi ≥ 0 were incorporated by normalizing g by its length and by
restricting the search space to gi ≥ 0.
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Figure 1: Deconvolution performance
with only a single reference profile
(macrophages). Predicted cell frequen-
cies are plotted versus real frequencies.
Results from the standard DTD model
with g = 1 are shown in (a), for DTD
with loss-function learning in (b).
3 Results
3.1 DTD of melanomas
For both training and validation we need expression profiles of cellular mixtures of known composi-
tion. We used expression data of melanomas whose composition has been experimentally resolved
using single-cell RNAseq profiling (Tirosh et al., 2016). These data included 4,645 single-cell pro-
files from 19 melanomas. The cells were annotated as T cells (2,068), B cells (515), macrophages
(126), endothelial cells (65), cancer-associated fibroblasts (CAFs) (61), natural killer (NK) cells
(52), and tumor/unclassified (1,758). The first 9 melanomas defined our validation cohort and the
remaining 10 our training data.
First, data were transformed into transcripts per million. Then, for each cell cluster we sampled
20% of single-cell profiles in the training data, summed them up, normalized them to a common
number of counts, and removed them from the training data. This yielded reference profiles X·,j .
The 1,000 genes with the highest variance across all reference profiles were used to train models.
The sum of all single-cell profiles of a melanoma gave us bulk profiles. In addition, we generated
a large number of artificial bulk profiles by randomly sampling single-cell profiles and summing them
up. All bulk profiles were normalized to the same number of reads as those in X·,j .
3.2 Loss-function learning improves DTD accuracy in the case of incomplete
reference data
We generated 2,000 artificial cellular mixtures from our training cohort. For each of these mixtures,
we randomly drew 100 single-cell profiles, summed up their raw counts, and normalized them to a
fixed number of total counts. Analogously, we generated 1,000 artificial cellular validation mixtures.
Then, we restricted X to three cell types (T cells, B cells, and macrophages). Hence endothelial
cells, CAFs, NK cells and tumor/unclassified cells in the mixtures are not represented in X. For
standard DTD with g = (1, . . . , 1), we observed correlation coefficients of 0.70 (T cells), 0.39 (B
cells), and 0.52 (macrophages) between true and estimated cell population sizes for the validation
mixtures. These improved to 0.86 (T cells), 0.89 (B cells), and 0.83 (macrophages) for loss-function
learning, after we ran 1000 iterations of the gradient descent algorithm on the training data.
To test the limits of the approach, we excluded all but the macrophages, which account for less
than 3% of all cells, from the reference data X. We observed, that standard DTD broke down, while
loss-function learning yielded a model that predicted macrophage abundances that still correlated
well (r = 0.84) with the true abundances (Figure 1).
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Figure 2: Plot (a) shows how the correlation between predicted and true cellular frequencies for
B cells depends on the proportion of B cells. The blue triangles correspond to models from loss-
function learning and red diamonds to the standard DTD model with g = 1. Furthermore, the
green stars show how the model trained on mixtures with 0 to 5% B cells extrapolates to higher
B-cell proportions. Plot (b) shows a heatmap of the 50 most important genes corresponding to the
green star model (genes were ranked by gˆi × var(Xi,·)). Plot (c) shows an analogous heatmap for
loss-function learning on macrophages only. Blue corresponds to low expression and red to high
expression.
3.3 Loss-function learning improves the quantification of small cell populations
We generated data as above but this time controlling the abundance of B cells in the simulated
mixtures at 0 to 5 cells, 5 to 15, 15 to 30, 30 to 50, and 50 to 75 out of 100 cells. Not surprisingly,
small fractions of B cells were harder to quantify than large ones. Loss-function learning improved
the accuracy for all amounts of B cells, but the improvements were greatest for small amounts
(Figure 2a). With only 0 to 5 cells in a mixture the accuracy improved from r = 0.22 to r = 0.79.
Furthermore, we observed that loss-function learning on small B-cell proportions yielded a model
that was highly predictive of B-cell contributions over the whole spectrum (Figure 2a green stars).
If we compare the top-ranked genes of the model learned for the small B-cell population (Fig-
ure 2b) to that of the macrophage-focussed simulation (Figure 2c), we observe that the former
still comprises marker genes to distinguish all cell types, while the latter focusses on genes that
characterize macrophages.
3.4 Loss-function learning improves the distinction of closely related cell types
The cell types that were annotated by Tirosh et al. (2016) displayed very different expression
profiles. If we are interested in T-cell subtypes such as CD8+ T cells, CD4+ T-helper (Th) cells,
and regulatory T cells (Tregs), reference profiles are more similar and DTD is more challenging. We
subdivided the fraction of annotated T-cell profiles as follows: all T cells with positive CD8 (sum
of CD8A and CD8B) and zero CD4 count were labelled CD8+ T cells (1,130). Vice versa, T cells
with zero CD8 and positive CD4 count were labelled CD4+ T cells (527). These were further split
into Tregs if both their FOXP3 and CD25 (IL2RA) count was positive (64), and CD4+ Th cells
otherwise (463). T cells that fulfilled neither the CD4+ nor the CD8+ criteria (411) contributed to
the mixtures, but were not assessed by DTD. We augmented the reference matrix X, here consisting
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Figure 3: Deconvolution of T-cell suben-
tities. Results from the standard DTD
model with g = 1 are shown in the upper
row, plots (a-c), results from loss-function
learning in the lower row, plots (d-e).
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Figure 4: Performance with and without loss-function learning
as a function of the size of the training set. Performance was as-
sessed by calculating the average correlations between predicted
and true cellular contributions over all cell types. The blue di-
amonds and black triangles correspond to the performance of
loss-function learning for the validation mixtures and training
mixtures, respectively. The performance of standard DTD with
g = 1 is shown as a red line for the validation mixtures.
of T cells, B cells, macrophages, endothelial cells, CAFs and NK cells, by these cell types, replacing
the original all T-cell profile with the more specific profiles for CD8+, CD4+ Th and Tregs. Then
we simulated 2,000 training and 1,000 test mixtures as described above.
For standard DTD with g = 1 we observed correlation coefficients of 0.19 (CD4+ Th), 0.53
(CD8+), and 0.08 (Tregs) between true and estimated cell population sizes. These improved to
0.58 (CD4+ Th), 0.78 (CD8+), and 0.57 (Tregs) for our method (Figure 3).
3.5 Loss-function learning is beneficial even for small training sets, and the
performance improves as the training dataset grows
We repeated the simulation in subsection 3.4, but varied the size of the training dataset. We
observed that loss-function learning improved accuracy for training datasets as small as 15 samples.
Moreover, with more training data added the boost in performance grew and saturated only for
training sets with more than 1,000 samples (Figure 4).
3.6 HPC-empowered loss-function learning rediscovers established cell markers
and complements them by new discriminatory genes for improved perfor-
mance
Here, we introduce a final model, optimized on the 5,000 most variable genes. For this purpose,
we generated 25,000 training mixtures from the melanomas of the training data. With standard
6
desktop workstations the solution of this problem was computationally not feasible. A single
computation of the gradient took 16 hours (2x Intel Xeon CPU [X5650; Nehalem Six Core, 2.67
GHz], 148 Gb RAM), and this needs to be computed several hundred times until convergence.
Therefore, we developed a High-Performance-Computing (HPC) implementation of our code by
parallelizing equations (3) and (6) with MPI, using the pbdMPI library (Chen et al. (2012b), Chen
et al. (2012a)) as an interface. Furthermore, we linked R with the Intel Math Kernel Library for
threaded and vectorized matrix operations. We ran the algorithm on 25 nodes of our QPACE 3
machine (Georg et al., 2017) with 8 MPI tasks per node and 32 hardware threads per task, where
each thread can use two AVX512 vector units. In 16 hours 5,086 iterations were finished, after
which the loss (3) was stable to within 1%.
The high-performance model includes several genes, whose expression is characteristic for the
cells distinguished in the present study. These include, among others, the CD8A gene, which
encodes an integral membrane glycoprotein essential for the activation of cytotoxic T-lymphocytes
(Veillette et al., 1988) and the protection of a subset of NK cells against lysis, thus enabling them in
contrast to CD8- NK cells to lyse multiple target cells (Addison et al., 2005). As evident from Figure
5, NK cells are clearly set apart from all the other cell types studied by the expression of the killer cell
lectin like receptor genes KLRB1, KLRC1, and KLRF1 (Moretta et al., 2001). B cells, on the other
hand, are clearly characterized by the expression of (i) CD19, which assembles with the antigen
receptor of B lymphocytes and influences B-cell selection and differentiation (Rickert et al., 1995),
(ii) CD20 (MS4A1), which is coexpressed with CD19 and functions as a store-operated calcium
channel (Li et al., 2003), (iii) B Lymphocyte Kinase (BLK), a src-family protein tyrosine kinase
that plays an important role in B-cell receptor signaling and phosphorylates specifically (iv) CD79A
at Tyr-188 and Tyr-199 as well as CD79B (not among the top 150 genes) at Tyr-196 and Tyr-207,
which are required for the surface expression and function of the B-cell antigen receptor complex
(Hsueh and Scheuermann (2000)), and (v) BLNK, which bridges BLK activation with downstream
signaling pathways (Wienands et al., 1998). The expression of FOXP3 is also highly cell specific.
FOXP3 distinguishes regulatory T cells from other CD4+ cells and functions as a master regulator
of their development and function (Hori et al. (2003)). Finally, CD4+ T-helper (Th) cells are
distinguished indirectly from all the other aforementioned lymphocytes by the lack of expression
of cell type-specific genes. In contrast to lymphocytes, macrophages, cancer-associated fibroblasts
(CAFs), and endothelial cells, which line the interior surface of blood vessels and lymphatic vessels,
are characterized each by a much larger number of genes. Exemplary genes include CD14, CD163,
MSR1, STAB1, and CSF1R for macrophages. The monocyte differentiation antigen CD14, for
instance, mediates the innate immune response to bacterial lipopolysaccharide (LPS) by activating
the NF-κB pathway and cytokine secretion (Haziot et al. (1996)), while the colony stimulating
factor 1 receptor (CSF1R) acts as a receptor for the hematopoietic growth factor CSF1, which
controls the proliferation and function of macrophages (Sherr et al. (1985)). CAFs, on the other
hand, are distinguished by the expression of genes encoding extracellular matrix proteins such
as fibulin-2 (FBLN2) and fibulin-3 (EFEMP1), various collagens (COL1A1, COL3A1, COL6A1,
COL6A3), versican (VCAN), a well known mediator of cell-to-cell and cell-to-matrix interactions
(Wu et al. (2005)) that plays critical roles in cancer biology (Du et al. (2013)), as well as the matrix
metalloproteinases MMP1 and MMP2, two collagen degrading enzymes that allow cancer cells to
migrate out of the primary tumor to form metastases (Gupta et al. (2014)). Noteworthy is also
GREM1, an antagonist of the bone morphogenetic protein pathway. Its expression and secretion
by stromal cells in tumor tissues promotes the survival and proliferation of cancer cells (Sneddon
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et al., 2006). Genes characteristic for endothelial cells include among others CDH5, a member
of the cadherin superfamily essential for endothelial adherens junction assembly and maintenance
(Gory-Faure et al. (1999)), the endothelial cell-specific chemotaxis receptor (ECSCR) gene, which
encodes a cell-surface single-transmembrane domain glycoprotein that plays a role in endothelial
cell migration, apoptosis and proliferation (Shi et al. (2011)), claudin-5 (CLDN5), which forms the
backbone of tight junction strands between endothelial cells (Haseloff et al., 2015), and the von
Willebrand factor (VWF), which mediates the adhesion of platelets to sites of vascular damage
by binding to specific platelet membrane glycoproteins and to constituents of exposed connective
tissue (Sadler (1998)).
We discussed 29 genes of the top 150 shown in Figure 5. These genes have a total weight of 28%
of all 5,000 gene weights (calculated as gˆi × var(Xi,·)). Our algorithm complements this gene set
with additional genes, including many that were, to our knowledge, not yet used to characterize cell
types. An interesting example is CXorf36 (DIA1R), which has been described as being expressed
at low levels in many tissues and deletion and/or mutations of which have been associated with
autism spectrum disorders (Aziz et al., 2011). However, nothing is known about its function to
date. Therefore, its observed overexpression in endothelial cells may provide an important clue for
future study on its function.
3.7 Loss-function learning shows similar performance as CIBERSORT for the
dominating cell populations and improves accuracy for small populations
and in the distinction of closely related cell types
Next we compared our model trained in subsection 3.6 to a competing method. For this, we
generated 1,000 test mixtures from our validation melanomas. We chose CIBERSORT (Newman
et al., 2015) for comparison, because it was consistently among the best DTD algorithm in a broad
comparison of five different algorithms on several benchmark datasets (Newman et al., 2015). We
ran CIBERSORT on the test mixtures, using two distinct approaches: first, we uploaded our
validation data to CIBERSORT using their reference profiles. The performance is summarized in
Figure 6 as CIBERSORTa (yellow). We observed that the large population of B cells was estimated
accurately, while smaller populations were inaccurate (NK cells, Tregs). Next, we uploaded our
reference profiles and used the CIBERSORT gene selection (CIBERSORTb green). We found that
highly abundant cell types (B cells and CD8+ T cells) were predicted with high accuracy. However,
the distinction of similar cell types such as CD4+ T helper cells and Tregs was compromised,
r = 0.42 and r = 0.42, respectively. Similarly, predictions for the small populations of CAFs were
compromised. That might be explained by the fact that CIBERSORT does not take into account
their distinction and thus appropriate marker genes might be missing. In a direct comparison to
CIBERSORT our method showed similar or better performance.
3.8 Loss-function learning improves the decomposition of bulk melanoma pro-
files
All mixtures discussed so far were artificial because only 100 single-cell profiles were chosen ran-
domly. They might differ significantly from mixtures in real tissue. Therefore, we generated 19
full bulk melanoma profiles by summing up the respective single-cell profiles. These should reflect
bulk melanomas (Marinov et al., 2014). Our predictions are contrasted with the true proportions
in Figure 7. Only the predictions for Tregs were compromised with r = 0.48, while the predictions
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Figure 5: Heatmap of X for the features with the top 150 weights (gˆi×var(Xi,·)). Blue corresponds
to low expression and red to high expression. The data were clustered by Euclidean distance.
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Figure 6: Performance comparison. The methods are from left to right: loss-function learning
(blue), standard DTD with g = 1 on the 5,000 most variable genes (red), CIBERSORTa (yellow),
CIBERSORTb (green). Performance was calculated as correlation between predicted and true
frequencies on 1,000 validation mixtures. Endothelial cells (endo.) and CAFs were not estimated
by CIBERSORTa and thus are not shown.
for all other cell types were reliable with correlations ranging from r = 0.70 (CD4+ Th) to r = 0.99
(CAFs) on the validation melanomas.
4 Discussion
We suggest loss-function learning for digital tissue deconvolution to adapt the deconvolution algo-
rithm to the requirements of specific application domains. The concept is similar to an embedded
feature-selection approach in regression or classification problems. In both contexts feature selec-
tion is directly linked to a prediction algorithm and not treated as an independent preprocessing
step.
We described and tested a specific instance of loss-function learning using squared residuals for
Lg. The concept is not limited to this type of inner loss function and can also be used in combination
with other loss functions such as those from penalized least-squares regression (Altboum et al.,
9
l
l
l
l
l
l
l
l
l
0.0 0.1 0.2 0.3 0.4
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
B cells
true C
pr
ed
ict
ed
 C
(a)
l 0.977
0.951
l
l
ll
l
l
l
l
l
0.00 0.05 0.10 0.15
0.
00
0.
05
0.
10
0.
15
0.
20
macrophages
true C
pr
ed
ict
ed
 C
(b)
l 0.97
0.991
l
l
l
l
l
l
l
0.00 0.02 0.04 0.06 0.08
0.
00
0.
02
0.
04
0.
06
0.
08
endothelial cells
true C
pr
ed
ict
ed
 C
(c)
l 0.915
0.929
l
l
l
l
l
0.00 0.02 0.04 0.06 0.08 0.10
0.
00
0.
05
0.
10
0.
15
CAFs
true C
pr
ed
ict
ed
 C
(d)
l 0.99
0.916
l
ll
l
l l
l
l
l
0.00 0.02 0.04 0.06 0.08
0.
00
0.
02
0.
04
0.
06
NK cells
true C
pr
ed
ict
ed
 C
(e)
l 0.941
0.966
l
l
l
l
l
ll
l
l
0.00 0.10 0.20 0.30
0.
1
0.
2
0.
3
0.
4
0.
5
CD4+ Th cells
true C
pr
ed
ict
ed
 C
(f)
l 0.699
0.824
l
l
l
l
l
l
l
l
l
0.0 0.2 0.4 0.6 0.8 1.0
0.
2
0.
4
0.
6
0.
8
1.
0
CD8+ T cells
true C
pr
ed
ict
ed
 C
(g)
l 0.987
0.988
l
l
l
l
l
l
l
l
l
0.00 0.02 0.04 0.06
0.
00
0.
02
0.
04
0.
06
0.
08
CD4+ Tregs
true C
pr
ed
ict
ed
 C
(h)
l 0.478
0.881
Figure 7: Deconvolution of melanoma tissues. The circles indicate melanomas from the validation
data and plusses from the training data. Figure (a) to (h) correspond to B cells, macrophages,
endothelial cells, CAFs, NK cells, CD4+ Th cells, CD8+ T cells, and CD4+ Tregs, respectively.
The solid black lines show the corresponding linear regression fits, the dashed lines the identity.
2014), l1 regression, or support vector regression (Newman et al., 2015). However, the least-
squares loss function allowed us to state the outer optimization problem in a closed analytical
form, reducing computational burden.
The outer loss function L evaluates the fit of estimated and true cellular proportions in the
training samples. We chose the correlation of estimated versus true quantities across samples, and
no absolute measure of deviation such as ||c − cˆ||22. Moreover, we did not require the estimated
proportions Cˆ·,k for tissue k to sum up to one. Consequently, when testing our method we did not
look at absolute deviations of true versus estimated cell proportions but only at their correlation.
We cannot reliably infer how many cells of a specific type (e.g., T cells) are in a tissue (Figure 7),
nor can we infer whether they constituted 10% or 20% of the cells in this tissue. However, if we
had two tissues and estimated that there were more cells of that type in the first tissue compared
to the second, this relation was also found in the true cell populations. Calibrating the method to
absolute cell numbers or percentages within a tissue appears to be difficult. This might be due to
the normalization of the libraries from single cells to a common size, which might not reflect true
biology if, for example, some cell types contain more RNA than others. Post-hoc normalization of
the estimated quantities might be an option.
In summary, we introduced loss-function learning as a new machine-learning approach to the
digital tissue deconvolution problem. It allows us to adapt to application-specific requirements
such as focusing on small cell populations or delineating similar cell types. In simulations and in an
application to melanoma tissues our method quantified large cell fractions as accurately as existing
methods and significantly improved the detection of small cell populations and the distinction of
similar cell types.
10
5 Acknowledgement
This work was supported by BMBF (eMed Grant 031A428A) and DFG (FOR-2127 and SFB/TRR-
55).
References
Abbas, A. R., Wolslegel, K., Seshasayee, D., Modrusan, Z., and Clark, H. F. (2009). Deconvolution
of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus.
PloS One, 4(7):e6098.
Addison, E. G., North, J., Bakhsh, I., Marden, C., Haq, S., Al-Sarraj, S., Malayeri, R., Wickre-
masinghe, R. G., Davies, J. K., and Lowdell, M. W. (2005). Ligation of CD8 on human natural
killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology,
116(3):354–361.
Altboum, Z., Steuerman, Y., David, E., Barnett-Itzhaki, Z., Valadarsky, L., Keren-Shaul, H.,
Meningher, T., Mendelson, E., Mandelboim, M., Gat-Viks, I., et al. (2014). Digital cell quan-
tification identifies global immune cell dynamics during influenza infection. Molecular Systems
Biology, 10(2):720.
Aziz, A., Harrop, S. P., and Bishop, N. E. (2011). Dia1r is an x-linked gene related to deleted in
autism-1. PLoS One, 6(1):e14534.
Bendall, S. C., Simonds, E. F., Qiu, P., El-ad, D. A., Krutzik, P. O., Finck, R., Bruggner, R. V.,
Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011). Single-cell mass cytometry of differential
immune and drug responses across a human hematopoietic continuum. Science, 332(6030):687–
696.
Chen, W.-C., Ostrouchov, G., Schmidt, D., Patel, P., and Yu, H. (2012a).
A Quick Guide for the pbdMPI Package. R Vignette, URL https://cran.r-
project.org/package=pbdMPI.
Chen, W.-C., Ostrouchov, G., Schmidt, D., Patel, P., and Yu, H. (2012b). pbdMPI: Programming
with Big Data – Interface to MPI. R Package, URL https://cran.r-project.org/package=pbdMPI.
Du, W., Yang, W., and J Yee, A. (2013). Roles of versican in cancer biology - Tumorigenesis,
progression and metastasis. Histology and Histopathology, 28(6):701–713.
Fridman, W. H., Pages, F., Sautes-Fridman, C., and Galon, J. (2012). The immune contexture in
human tumours: impact on clinical outcome. Nature Reviews Cancer, 12(4):298.
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Page`s, C., Tosolini,
M., Camus, M., Berger, A., Wind, P., et al. (2006). Type, density, and location of immune cells
within human colorectal tumors predict clinical outcome. Science, 313(5795):1960–1964.
Georg, P., Richtmann, D., and Wettig, T. (2017). DD-αAMG on QPACE 3. arXiv.org, 1710.07041.
11
Gong, T., Hartmann, N., Kohane, I. S., Brinkmann, V., Staedtler, F., Letzkus, M., Bongiovanni,
S., and Szustakowski, J. D. (2011). Optimal deconvolution of transcriptional profiling data
using quadratic programming with application to complex clinical blood samples. PloS One,
6(11):e27156.
Gory-Faure, S., Prandini, M., Pointu, H., Roullot, V., Pignot-Paintrand, I., Vernet, M., and Hu-
ber, P. (1999). Role of vascular endothelial-cadherin in vascular morphogenesis. Development,
126(10):2093–2102.
Gupta, A., Kaur, C. D., Jangdey, M., and Saraf, S. (2014). Matrix metalloproteinase enzymes and
their naturally derived inhibitors: Novel targets in photocarcinoma therapy. Ageing Research
Reviews, 13(Supplement C):65–74.
Hackl, H., Charoentong, P., Finotello, F., and Trajanoski, Z. (2016). Computational genomics tools
for dissecting tumour-immune cell interactions. Nature Reviews Genetics, 17(8):441–458.
Haseloff, R. F., Dithmer, S., Winkler, L., Wolburg, H., and Blasig, I. E. (2015). Transmembrane
proteins of the tight junctions at the blood–brain barrier: structural and functional aspects. In
Seminars in cell & developmental biology, volume 38, pages 16–25. Elsevier.
Haziot, A., Ferrero, E., Ko¨ntgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L., and
Goyert, S. M. (1996). Resistance to Endotoxin Shock and Reduced Dissemination of Gram-
Negative Bacteria in CD14-Deficient Mice. Immunity, 4(4):407–414.
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of Regulatory T Cell Development by the
Transcription Factor Foxp3. Science, 299(5609):1057–1061.
Hsueh, R. C. and Scheuermann, R. H. (2000). Tyrosine kinase activation in the decision be-
tween growth, differentiation, and death responses initiated from the B cell antigen receptor. In
Advances in Immunology, volume Supplement C (75), pages 283–316. Academic Press.
Ibrahim, S. F. and van den Engh, G. (2007). Flow cytometry and cell sorting. In Cell Separation,
pages 19–39. Springer.
Li, B., Severson, E., Pignon, J.-C., Zhao, H., Li, T., Novak, J., Jiang, P., Shen, H., Aster, J. C.,
Rodig, S., et al. (2016). Comprehensive analyses of tumor immunity: implications for cancer
immunotherapy. Genome Biology, 17(1):174.
Li, H., Ayer, L. M., Lytton, J., and Deans, J. P. (2003). Store-operated Cation Entry Mediated by
CD20 in Membrane Rafts. Journal of Biological Chemistry, 278(43):42427–42434.
Lu, P., Nakorchevskiy, A., and Marcotte, E. M. (2003). Expression deconvolution: a reinterpretation
of DNA microarray data reveals dynamic changes in cell populations. Proceedings of the National
Academy of Sciences USA, 100(18):10370–10375.
Marinov, G. K., Williams, B. A., McCue, K., Schroth, G. P., Gertz, J., Myers, R. M., and Wold,
B. J. (2014). From single-cell to cell-pool transcriptomes: stochasticity in gene expression and
RNA splicing. Genome Research, 24(3):496–510.
12
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., and
Moretta, L. (2001). Activating receptors and coreceptors involved in human natural killer cell-
mediated cytolysis. Annual Review of Immunology, 19(1):197–223. PMID: 11244035.
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn,
M., and Alizadeh, A. A. (2015). Robust enumeration of cell subsets from tissue expression
profiles. Nature Methods, 12(5):453–457.
Qiao, W., Quon, G., Csaszar, E., Yu, M., Morris, Q., and Zandstra, P. W. (2012). PERT: a
method for expression deconvolution of human blood samples from varied microenvironmental
and developmental conditions. PLoS Computational Biology, 8(12):e1002838.
Rickert, R. C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-dependent B-cell responses
and B-l cell development in CD19-deficient mice. Nature, 376(6538):352–355. 10.1038/376352a0.
Sadler, J. E. (1998). Biochemistry and Genetics of von Willebrand Factor. Annual Review of
Biochemistry, 67(1):395–424. PMID: 9759493.
Sherr, C. J., Rettenmier, C. W., Sacca, R., Roussel, M. F., Look, A. T., and Stanley, E. R. (1985).
The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte
growth factor, CSF 1. Cell, 41(3):665–676.
Shi, C., Jia, L., Wen, W., Fanxin, M., Joseph, G., Hanju, H., James, B., Yongchang, C., and Yao,
H. (2011). Endothelial Cell-Specific Molecule 2 (ECSM2) Localizes to Cell-Cell Junctions and
Modulates bFGF-Directed Cell Migration via the ERK-FAK Pathway. PloS One, 6(6):1–15.
Sneddon, J. B., Zhen, H. H., Montgomery, K., van de Rijn, M., Tward, A. D., West, R., Gladstone,
H., Chang, H. Y., Morganroth, G. S., Oro, A. E., et al. (2006). Bone morphogenetic protein
antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote
tumor cell proliferation. Proceedings of the National Academy of Sciences USA, 103(40):14842–
14847.
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem,
A., Rodman, C., Lian, C., Murphy, G., et al. (2016). Dissecting the multicellular ecosystem of
metastatic melanoma by single-cell RNA-seq. Science, 352(6282):189–196.
Veillette, A., Bookman, M. A., Horak, E. M., and Bolen, J. B. (1988). The CD4 and CD8 T cell
surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell,
55(2):301–308.
Wienands, J., Schweikert, J., Wollscheid, B., Jumaa, H., Nielsen, P. J., and Reth, M. (1998). Slp-65:
a new signaling component in b lymphocytes which requires expression of the antigen receptor
for phosphorylation. Journal of Experimental Medicine, 188(4):791–795.
Wu, A. R., Neff, N. F., Kalisky, T., Dalerba, P., Treutlein, B., Rothenberg, M. E., Mburu, F. M.,
Mantalas, G. L., Sim, S., Clarke, M. F., et al. (2014). Quantitative assessment of single-cell
RNA-sequencing methods. Nature Methods, 11(1):41–46.
Wu, Y. J., La Pierre, D. P., Wu, J., Yee, A. J., and Yang, B. B. (2005). The interaction of versican
with its binding partners. Cell Research, 15(7):483–494.
13
